PRECISO delivers whole-genome sequencing and clinically oriented interpretation designed to support early-life programs, longitudinal insight, and enterprise integration—under governance-first operating standards.
PRECISO is Renoviant’s precision genomics and clinical intelligence capability—built to generate high-quality genomic signal and interpretation within a governed, program-ready operating model.
Genomic data only becomes valuable when it is clinically interpretable, operationally deployable, and responsibly governed. PRECISO is structured to support real-world decisioning and longitudinal insight while meeting enterprise expectations.
PRECISO operates as a focused healthcare capability while aligning with Renoviant’s shared-services platform, data standards, and governance controls.
Platform Overview →Designed for enterprise environments where clinical standards, privacy controls, and operational clarity are non-negotiable.